BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mascolo A, Scavone C, Sessa M, di Mauro G, Cimmaruta D, Orlando V, Rossi F, Sportiello L, Capuano A. Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting. Pharmacol Res 2017;123:122-9. [PMID: 28694146 DOI: 10.1016/j.phrs.2017.07.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Barbieri MA, Cutroneo PM, Baratelli C, Cicala G, Battaglia A, Santoro V, Andò G, Spina E. Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database. J Clin Pharm Ther 2021;46:1027-40. [PMID: 33646603 DOI: 10.1111/jcpt.13391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Mascolo A, Ruggiero R, Sessa M, Scavone C, Sportiello L, Rafaniello C, Rossi F, Capuano A. Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System. Front Pharmacol 2019;10:425. [PMID: 31114497 DOI: 10.3389/fphar.2019.00425] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
3 Scavone C, Di Mauro C, Brusco S, Bertini M, di Mauro G, Rafaniello C, Sportiello L, Rossi F, Capuano A. Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy. Expert Opinion on Drug Safety 2019;18:427-33. [DOI: 10.1080/14740338.2019.1598969] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Očovská Z, Maříková M, Kočí J, Vlček J. Drug-Related Hospital Admissions via the Department of Emergency Medicine: A Cross-Sectional Study From the Czech Republic. Front Pharmacol 2022;13:899151. [DOI: 10.3389/fphar.2022.899151] [Reference Citation Analysis]
5 Hussain SA, Abbas AN, Habeeb SA, Abd-ali AK, Abdulrahman ZS. Healthcare personnel’s experience of reporting adverse drug reactions in Baghdad city: cross-sectional study. Int J Clin Pharm 2019;41:1307-13. [DOI: 10.1007/s11096-019-00867-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Sessa M, Mascolo A, Callréus T, Capuano A, Rossi F, Andersen M. Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®. Sci Rep 2019;9:7236. [PMID: 31076635 DOI: 10.1038/s41598-019-43715-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
7 Scavone C, Stelitano B, Rafaniello C, Rossi F, Sportiello L, Capuano A. Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System. J Gambl Stud 2020;36:85-96. [PMID: 30671764 DOI: 10.1007/s10899-019-09828-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Baré M, Herranz S, Jordana R, Gorgas MQ, Ortonobes S, Sevilla D, De Jaime E, Ibarra O, Martín C; MoPIM study group. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM. BMJ Open 2020;10:e033322. [PMID: 31988230 DOI: 10.1136/bmjopen-2019-033322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Argyriou AA, Kalofonou F, Litsardopoulos P, Anastopoulou GG, Kalofonos HP. Oxaliplatin rechallenge in metastatic colorectal cancer patients with clinically significant oxaliplatin-induced peripheral neurotoxicity. J Peripher Nerv Syst 2021;26:43-8. [PMID: 33345432 DOI: 10.1111/jns.12426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Jatau AI, Shitu Z, Khalid GM, Yunusa I, Awaisu A. Understanding adverse drug-related emergency department visits: development of a conceptual model through a systematic review. Ther Adv Drug Saf 2019;10:2042098619852552. [PMID: 31258886 DOI: 10.1177/2042098619852552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sessa M, Rafaniello C, Scavone C, Mascolo A, di Mauro G, Fucile A, Rossi F, Sportiello L, Capuano A. Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? Expert Opin Drug Saf 2018;17:457-65. [PMID: 29619841 DOI: 10.1080/14740338.2018.1458837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Sessa M, Andersen M. New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database. BioDrugs 2021;35:215-27. [PMID: 33609278 DOI: 10.1007/s40259-021-00469-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ruggiero R, Stelitano B, Fraenza F, di Mauro G, Scavone C, Sportiello L, Rafaniello C, Di Napoli R, Danesi R, Del Re M, Rossi F, Capuano A. Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data. Front Oncol 2022;12:824511. [PMID: 35372076 DOI: 10.3389/fonc.2022.824511] [Reference Citation Analysis]
14 Scavone C, di Mauro G, Mascolo A, Berrino L, Rossi F, Capuano A. The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. Front Pharmacol 2019;10:111. [PMID: 30814951 DOI: 10.3389/fphar.2019.00111] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
15 Mcconachie SM, Caputo RA, Wilhelm SM, Kale-pradhan PB. Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review. Ann Pharmacother 2019;53:1145-52. [DOI: 10.1177/1060028019852601] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
16 Andrade PHS, de Almeida ACB, Dos Santos AKS, Lobo IMF, da Silva FA, da Silva WB. Challenges to the consolidation of pharmacovigilance practices in Brazil: limitations of the hospital pharmacist. Ther Adv Drug Saf 2020;11:2042098620933748. [PMID: 32864089 DOI: 10.1177/2042098620933748] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ziemssen F, Hammer T, Grueb M, Mueller B, Berk H, Gamulescu MA, Voegeler J, Wachtlin J, Ocean Study Group. Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial. J Ophthalmol 2020;2020:8652370. [PMID: 33083052 DOI: 10.1155/2020/8652370] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Sessa M, Mascolo A, Scavone C, Perone I, Di Giorgio A, Tari M, Fucile A, De Angelis A, Rasmussen DB, Jensen MT, Kragholm K, Rossi F, Capuano A, Sportiello L. Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study. Front Pharmacol 2018;9:1212. [PMID: 30459608 DOI: 10.3389/fphar.2018.01212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Vélez-Díaz-Pallarés M, Pérez-Menéndez-Conde C, Bermejo-Vicedo T. Systematic review of computerized prescriber order entry and clinical decision support. Am J Health Syst Pharm 2018;75:1909-21. [PMID: 30463867 DOI: 10.2146/ajhp170870] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
20 de Fraga RS, Van Vaisberg V, Mendes LCA, Carrilho FJ, Ono SK. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review. J Gastroenterol 2020;55:496-514. [PMID: 32185517 DOI: 10.1007/s00535-020-01680-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
21 Largeau B, Boels D, Victorri-Vigneau C, Cohen C, Salmon Gandonnière C, Ehrmann S. Posterior Reversible Encephalopathy Syndrome in Clinical Toxicology: A Systematic Review of Published Case Reports. Front Neurol 2019;10:1420. [PMID: 32116991 DOI: 10.3389/fneur.2019.01420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Moore N, Berdaï D, Blin P, Droz C. Pharmacovigilance - The next chapter. Therapie 2019;74:557-67. [PMID: 31623850 DOI: 10.1016/j.therap.2019.09.004] [Cited by in Crossref: 77] [Cited by in F6Publishing: 47] [Article Influence: 25.7] [Reference Citation Analysis]
23 Perez C, Olivier P, Lortal B, Duranton S, Montastruc JL, Colin AL, Toulza E, Becker M, Hamy L, Crepin S, Roussillon C, Gimbert A, Petitpain N, Salvo F. Detection of drug safety signals from clinical trials data: Role of SUSARs. Pharmacol Res 2018;131:218-23. [PMID: 29444478 DOI: 10.1016/j.phrs.2018.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
24 Guerriero F, Orlando V, Monetti VM, Colaccio FM, Sessa M, Scavone C, Capuano A, Menditto E. Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: a retrospective observational study in Southern Italy. Ther Clin Risk Manag 2018;14:1907-14. [PMID: 30349269 DOI: 10.2147/TCRM.S171346] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Lelièvre B, Drouillard I, Thill C, Le Roux G, Bruneau C, Mahé J, Deguigne M, Boels D. Severe poisoning with naproxen causing coagulopathy. Basic Clin Pharmacol Toxicol 2020;126:458-63. [PMID: 31742906 DOI: 10.1111/bcpt.13365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 Khalili M, Mesgarpour B, Sharifi H, Golozar A, Haghdoost AA. Estimation of adverse drug reaction reporting in Iran: Correction for underreporting. Pharmacoepidemiol Drug Saf 2021;30:1101-14. [PMID: 33772938 DOI: 10.1002/pds.5235] [Reference Citation Analysis]
27 Scavone C, Rafaniello C, Brusco S, Bertini M, Menditto E, Orlando V, Trama U, Sportiello L, Rossi F, Capuano A. Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization's Reporting? A Pharmacovigilance Study in Southern Italy. Front Pharmacol 2018;9:1003. [PMID: 30233378 DOI: 10.3389/fphar.2018.01003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]